NOT KNOWN FACTUAL STATEMENTS ABOUT HEMGENIX

Range of suitable people: CDEC discussed the uncertainty in the number of patients with reasonably intense to serious hemophilia B in Canada eligible for etranacogene dezaparvovec. Medical gurus consulted by CADTH indicated that some clients that are categorized as getting gentle or average sickness could possibly have a intense bleeding phenotype,